Page 265 - Binder2

• To cut biologic drug costs by orders of magnitude
• To deliver therapies in ways that induce immune
harmony, not disruption
• To make advanced medicine a global standard, not
a regional privilege
• To design health systems that treat access not as a
barrier—but as a built-in feature

This is more than innovation.
It’s reimagination.

Of where drugs come from.
Of how they reach the body.
Of how the body responds.
Of what kind of infrastructure we’ll need—not just for the
next market, but the next century.

The Future Is Edible

In the years ahead, we will still need traditional biologics.
But increasingly, we will need something else alongside
them:

• Drugs that don’t just disrupt disease, but teach the
immune system to adapt
• Therapeutics that can be grown anywhere, stored
anywhere, taken anywhere
• A class of medicine that belongs not just in vials—
but in capsules, sachets, and community clinics
• Biologics that look less like pharma—and more like
something new

Because the future of medicine isn’t just injectable.
It’s edible.

And it’s already on its way.

263